Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy.

Ítems similars

• Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: a case report.
  per: White, M C, et al.
  Publicat: (1981)
• Effect of continuous subcutaneous insulin infusion on retinopathy.
  per: Bastiaensen, L.
  Publicat: (1983)
• ABC of diabetes. Continuous subcutaneous insulin infusion.
  per: Pickup, J C
  Publicat: (1982)
• Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
  per: Lyu, Fu-ping, et al.
  Publicat: (2020)
• Changes in Insulin Requirements From the Onset of Continuous Subcutaneous Insulin Infusion (CSII) Until Optimization of Glycemic Control
  per: Chico, Ana, et al.
  Publicat: (2014)